Announcements
- Kuros reports Corporate Highlights as of Q1 2024 including increase in direct MagnetOsTM sales
- Annual General Meeting of Kuros Biosciences approves all resolutions
- Kuros reports 163% growth in direct MagnetOs sales and 153% increase in total medical device sales for the full year 2023
- Kuros Biosciences to Report Full Year Financial Results for 2023 and Provide Corporate Update
Key statistics
As of last trade Kuros Biosciences AG (YTSN:BRN) traded at 6.66, 0.00% below its 52-week high of 6.66, set on May 07, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 6.66 |
---|---|
High | 6.66 |
Low | 6.66 |
Bid | 5.62 |
Offer | -- |
Previous close | 6.48 |
Average volume | 626.50 |
---|---|
Shares outstanding | 36.92m |
Free float | 23.93m |
P/E (TTM) | -- |
Market cap | 243.69m CHF |
EPS (TTM) | -0.3697 CHF |
Data delayed at least 15 minutes, as of May 07 2024.
More ▼